153 related articles for article (PubMed ID: 33791213)
1. Lymphopenia in Esophageal Cancer: What Have We Learned?
Wang JL; Ma R; Kong W; Zhao R; Wang YY
Front Oncol; 2021; 11():625963. PubMed ID: 33791213
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
[TBL] [Abstract][Full Text] [Related]
3. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Ménétrier-Caux C; Ray-Coquard I; Blay JY; Caux C
J Immunother Cancer; 2019 Mar; 7(1):85. PubMed ID: 30922400
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors.
Venkatesulu BP; Mallick S; Lin SH; Krishnan S
Crit Rev Oncol Hematol; 2018 Mar; 123():42-51. PubMed ID: 29482778
[TBL] [Abstract][Full Text] [Related]
5. A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy.
Wang X; Wang P; Zhao Z; Mao Q; Yu J; Li M
Ther Adv Med Oncol; 2020; 12():1758835920926822. PubMed ID: 32518598
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
[TBL] [Abstract][Full Text] [Related]
7. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
8. Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.
Cho Y; Park S; Byun HK; Lee CG; Cho J; Hong MH; Kim HR; Cho BC; Kim S; Park J; Yoon HI
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1065-1073. PubMed ID: 31476418
[TBL] [Abstract][Full Text] [Related]
9. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
11. Lack of Lymphocyte Recovery After Esophagectomy Predicts Overall and Recurrence-Free Survival.
Hall BM; Geraci TC; Machan JT; Milman S; Adams CA; Cioffi W; Ng T; Monaghan S
J Surg Res; 2020 Feb; 246():379-383. PubMed ID: 31676146
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in endometrial cancer: rationale, practice and perspectives.
Cao W; Ma X; Fischer JV; Sun C; Kong B; Zhang Q
Biomark Res; 2021 Jun; 9(1):49. PubMed ID: 34134781
[TBL] [Abstract][Full Text] [Related]
13. Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment.
Ishikawa E; Yamamoto T; Sakamoto N; Nakai K; Akutsu H; Tsuboi K; Takano S; Matsumura A
Neurol Med Chir (Tokyo); 2010; 50(8):638-44. PubMed ID: 20805645
[TBL] [Abstract][Full Text] [Related]
14. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
15. Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Feng JF; Liu JS; Huang Y
Medicine (Baltimore); 2014 Dec; 93(27):e257. PubMed ID: 25501097
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia predicts poor prognosis in older gastric cancer patients after curative gastrectomy.
Tatara T; Suzuki S; Kanaji S; Yamamoto M; Matsuda Y; Hasegawa H; Yamashita K; Matsuda T; Oshikiri T; Nakamura T; Kakeji Y
Geriatr Gerontol Int; 2019 Dec; 19(12):1215-1219. PubMed ID: 31674139
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
Ayoub JP; Palmer JL; Huh Y; Cabanillas F; Younes A
Leuk Lymphoma; 1999 Aug; 34(5-6):519-27. PubMed ID: 10492075
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram.
van Rossum PSN; Deng W; Routman DM; Liu AY; Xu C; Shiraishi Y; Peters M; Merrell KW; Hallemeier CL; Mohan R; Lin SH
Pract Radiat Oncol; 2020; 10(1):e16-e26. PubMed ID: 31369887
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Pavan A; Calvetti L; Dal Maso A; Attili I; Del Bianco P; Pasello G; Guarneri V; Aprile G; Conte P; Bonanno L
Oncologist; 2019 Aug; 24(8):1128-1136. PubMed ID: 31015312
[TBL] [Abstract][Full Text] [Related]
20. Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.
Baharnoori M; Gonzalez CT; Chua A; Diaz-Cruz C; Healy BC; Stankiewicz J; Weiner HL; Chitnis T
Mult Scler Relat Disord; 2018 Feb; 20():51-57. PubMed ID: 29304497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
